MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Cytosorbents Corporation DIO Ratio 2011-2026 | CTSO
Annual DIO Ratio Cytosorbents Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106 | 137 | 108 | 123 | 79.1 | 105 | 40.6 | 52.6 | 77 | 196 | 92 | 46.9 | 780 | 13.4 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.4 K | 40.6 | 1.09 K |
Quarterly DIO Ratio Cytosorbents Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125 | 110 | 104 | - | 103 | 157 | 160 | - | 71.5 | 50.6 | 59.2 | - | 36 | 70 | 205 | - | 152 | 114 | 95.9 | - | 84.4 | 75.1 | 91.6 | - | 114 | 105 | 77.3 | - | 37 | 42.6 | 47.4 | - | 47.9 | 49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 205 | 36 | 91.7 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M |  USA |
 |
LivaNova PLC
LIVN
|
127 | $ 69.84 | 1.14 % | $ 3.79 B |  Britain |
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 6.61 | 3.44 % | $ 475 M |  Israel |
 |
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
Alphatec Holdings
ATEC
|
271 | $ 13.85 | -0.57 % | $ 2.08 B | USA |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
238 | $ 31.25 | -3.85 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
213 | $ 3.46 | -2.26 % | $ 120 M | USA |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
237 | $ 269.55 | 0.25 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 4.63 | 3.58 % | $ 173 M |  France |
 |
Bruker Corporation
BRKR
|
216 | $ 39.92 | 0.38 % | $ 5.95 K | USA |
 |
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
169 | $ 74.02 | -1.5 % | $ 110 B | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
220 | $ 15.18 | 4.3 % | $ 410 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
205 | $ 46.01 | -0.07 % | $ 1.43 B | USA |
 |
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
307 | $ 13.96 | -0.14 % | $ 902 M | Israel |
 |
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
302 | $ 10.16 | 2.11 % | $ 290 M | USA |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
91.2 | $ 23.53 | 1.64 % | $ 199 M | USA |
 |
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
511 | $ 77.39 | -2.87 % | $ 2.18 B |  Costa-rica |
 |
Nano-X Imaging Ltd.
NNOX
|
32.1 | $ 2.46 | 1.23 % | $ 144 M | Israel |
 |
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
13.9 | $ 18.54 | -0.16 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
270 | $ 95.57 | 3.99 % | $ 12.9 B | USA |
 |
Helius Medical Technologies
HSDT
|
327 | $ 2.18 | 17.84 % | $ 1.33 M | USA |
 |
IRadimed Corporation
IRMD
|
251 | $ 100.38 | 1.3 % | $ 1.27 B | USA |
 |
Invacare Corporation
IVC
|
82.8 | - | - | $ 24.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
205 | $ 11.54 | 0.09 % | $ 889 M | USA |
 |
Inogen
INGN
|
47 | $ 6.07 | 3.94 % | $ 144 M | USA |